A truncated galectin-3 isolated from skin mucus of Atlantic salmon Salmo salar binds to and modulates the proteome of the gram-negative bacteria Moritella viscosa
Patel, Deepti Manjari; Kitani, Yoichiro; Korsnes, Kjetil; Iversen, Martin Haugmo; Brinchmann, Monica Fengsrud
Peer reviewed, Journal article
Published version
Date
2020Metadata
Show full item recordCollections
Original version
Patel, D. M., Kitani, Y., Korsnes, K., Iversen, M. H. & Brinchmann, M. F. (2020). A truncated galectin-3 isolated from skin mucus of Atlantic salmon Salmo salar binds to and modulates the proteome of the gram-negative bacteria Moritella viscosa. Marine drugs, 18(2): 102. doi: 10.3390/md18020102Abstract
The mucus of fish skin plays a vital role in innate immune defense. Some mucus proteins have the potential to incapacitate pathogens and/or inhibit their passage through the skin. In this study the aim was to isolate and characterize galectin(s), β-galactosides binding proteins, present in skin mucus. A novel short form of galectin-3 was isolated from Atlantic salmon skin mucus by α-lactose agarose based affinity chromatography followed by Sephadex G-15 gel filtration. Mass spectrometric analysis showed that the isolated protein was the C-terminal half of galectin-3 (galectin-3C). Galectin-3C showed calcium independent and lactose inhabitable hemagglutination, and agglutinated the Gram-negative pathogenic bacteria Moritella viscosa. Galectin-3 mRNA was highly expressed in skin and gill, followed by muscle, hindgut, spleen, stomach, foregut, head kidney, and liver. Moritella viscosa incubated with galectin-3C had a modified proteome. Proteins with changed abundance included multidrug transporter and three ribosomal proteins L7/12, S2, and S13. Overall, this study shows the isolation and characterization of a novel galectin-3 short form involved in pathogen recognition and modulation, and hence in immune defense of Atlantic salmon.